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THE aim of the present study was to verify whether a
single oral dose ofmethylprednisolone could modulate the
exercise-induced release ofpolymorphonuclear neutrophil
(PMN) elastase and myeloperoxidase. Four healthy, male
subjects were submitted to a 20 min downhill run
(-20%) at 600/0 ro max, 3 h after oral absorption of a
placebo or a single dose of 32 mg methylprednisolone. A
marked neutrophilia (+103% of basal PMN count;
p< 0.02) was observed 3h after methylprednisolone
ingestion. During both exercise trials, placebo and
methylprednisolone, PMN counts were increased by 46%
and 19% (p < 0.05), respectively. The running test caused
marked and significant (p < 0.05) increases in plasma
myeloperoxidase concentration (MPO). The magnitude of
MPO changes was the same in the two trials (+ 110%).
Exercise also resulted in significant changes in plasma
elastase concentration (EL) in both experimental condi-
tions (placebo: +104%, p<0.05; methylprednisolone:
+338%, p < 0.005). Plasma elastase levels reached at the
end of exercise on methylprednisolone were significantly
higher than after placebo (p<0.05). A significant
relationship was found between EL and PMN in methyl-
prednisolone trial only (r--- 0.72; l0 < 0.005). These results
showed that the transient exercise-induced release of
elastase and myeloperoxidase were not decreased by
methylprednisolone.
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Introduction
The occurrence of transient exercise-induced
polymorphonuclear neutrophil (PMN) activation in
man has been demonstrated by several studies based
on the measurement of the plasma concentration of
specific markers of PMN activity.
1-s Increased
plasma levels of elastase (EL) l’s and myeloperox-
idase (MPO)2’4’s have been reported in subjects
submitted to various exercise protocols. It has been
suggested that PMN activation could be a part of
an acute inflammatory response to muscle and/or
adjacent connective tissue damage.3’s This working
hypothesis was substantiated by recent studies
arguing for the involvement of complement
activation4 and damaging contractions in the
process ofPMN activation, To date, there are few
data concerning the involvement of other mediators
capable of triggering or modulating the PMN
activity during exercise. Among these mediators are
several lipoxygenase and cyclooxygenase products
of arachidonic acid (AA) metabolism, such as
prostaglandins and leukotrienes. As inflammatory
mediators derived from arachidonic acid (AA) were
found to be released during exercise,
6 it seems
reasonable to suggest that they could be involved
in the inflammatory response to damaging contrac-
tions, and therefore, in the exercise-induced PMN
activation. Consistent with this view are the results
of a recent study by Hasson et aL7 where a potent
anti-inflammatory agent (ibuprofen) decreased the
delayed onset muscle soreness (DOMS), a symptom
of acute inflammation,
8 in subjects submitted to
strenuous exercise. As glucocorticoids are thought
to exert their anti-inflammatory effects by inducing
the synthesis of lipocortins which, in turn, inhibit
phospholipase A2 production of arachidonic acid,
9
we investigated whether methylprednisolone could
influence the transient exercise-induced increase of
plasma elastase and myeloperoxidase concentra-
tions. It has been shown that the easiest way of
producing muscle injury--and therefore, an in-
flammatory response to exercise---is to force the
muscles to contract while lengthening,8’1 as in
running downhill. These findings prompted us to
study the effects of a single oral dose of methyl-
prednisolone on the exercise-induced changes in
plasma levels of elastase and myeloperoxidase in
subjects submitted to a 20 min downhill run on an
inclined treadmill.
Methods
Four healthy male subjects (mean age 22 +_ 2
years; mean body weight" 74 +/- 2 kg) volunteered
to take part in the present investigation after
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approval of the experimental protocol by the Ethics
Committee. Informed consent was obtained from
each subject after the nature of the study had been
fully explained. During the study period, the
subjects were asked to abstain from taking any form
of medication. The subjects’ maximal oxygen
uptake (VO2max) was measured during the
course of a graded exercise test to volitional
exhaustion on a 10% inclined treadmill as described
previously.
11 Oxygen uptake (O2) was measured
by an open circuit method (Ergo-Oxyscreen,
Jaeger). The running speeds corresponding to
steady state rO2 equal to 60% of individual
gO2 max were calculated using the nomogram of
Margaria et al. 12 Two weeks after /rO2max
measurement, the subjects reported to the labor-
atory to complete the first of two 20 min downhill
runs on a 20% grade. The second run was separated
from the first by a period of at least 3 weeks during
which the subjects were asked to refrain from
strenuous exercise. These two trials were performed
in the morning after an overnight fast following the
same protocol.
A teflon catheter was inserted into an antecubital
vein and sealed. Four blood samples of 10 ml were
collected into plastic tubes containing EDTA" $1"
10 min after catheter insertion, just before inges-
tion of a capsule containing either a placebo
(control condition) or 32 mg methylprednisolone
(MEDROL, Upjohn); S2" 3 h after ingestion of a
placebo or the.drug. The subjects ran then for 20
min at the predetermined speed. Exercise rO2 was
monitored continuously during the downhill run
and the running speed was adjusted if necessary so
as to keep steady state gO2 as close as possible to
the predetermined value. Two post-exercise blood
samples were drawn" S3" immediately after the run;
S4" after 20 min recovery. Three millitres of whole
fresh blood were taken from each tube for leucocyte
count using a SYSMEX E-5000. The remaining
7 ml were centrifuged and the supernatants were
kept in sealed tubes at -70C for further analysis.
Plasma elastase concentration was assessed using an
immunoactivation method (Merck, Kit 11332).
13
Plasma myeloperoxidase concentration MPO was
assessed according to the radioimmunological
method described by Pincemail et a1.14 Preliminary
experiments showed that methylprednisolone was
without effect on elastase and myeloperoxidase
assays (unpublished results).
The occurrence of DOMS was recorded 48 h
after downhill runs by asking the subjects whether
they suffered from muscle pain during walking
upstairs and downstairs. Muscle soreness percep-
tion was evaluated using an arbitrary 10-point
rating scale (1 no pain, 10 very severe).
Values are expressed throughout this study as
means +__ SD. A two-way analysis of variance with
repeated measurements and Bonferroni’s post-hoc
test identified means which differed as a function of
time in the two experimental conditions. Differ-
ences between mean PMN and EL values obtained
after placebo and methylprednisolone at each time
point were evaluated using Student’s t-test for
paired observations. Statistical significance was
accepted at the 0.05 level. Given the low number
of subjects, statistical analysis was used as a trend
indicator.
Results
The subjects’ O2max averaged 55 + 3ml
O2/kg per min. Mean running speed was
11 + 2 km/h.
The effects of methylprednisolone on absolute
circulating neutrophil count (PMN) at rest and
during exercise are shown in Fig. 1. While resting
PMN count remained unchanged after placebo, a
marked neutrophilia (+ 103% of basal value;
p < 0.02) was observed 3 h after methylpredniso-
lone ingestion. At this time point, PMN count in
the placebo group was significantly lower than in
the methylprednisolone group (p < 0.05). During
both exercise trials, placebo and methylpredniso-
lone, PMN counts were increased by 46% and 19%
(p < 0.05), respectively. Mean PMN values after
methylprednisolone were significantly greater than
after placebo in blood samples taken just before,
immediately after exercise and during recovery
(p <0.05). During discovery, PMN decreased
slightly but remained significantly different from
baseline values measured 3 h before exercise.
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FIG. 1. Blood polymorphonuclear neutrophil counts as a function of
time in the two experimental conditions (Sl: 10 min after catheter
insertion; S2: 3h after ingestion of a capsule containing either a
placebo or 32 mg methylprednisolone; S3: immediately after the run;
S4: after 20 min recovery). Vertical bars are SD (n 0.4). *Significantly
different from pre-exercise level (S2): p < 0.05; **Significantly different
from baseline level: p < 0.02.
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At this time point, mean EL were 51 + 16
ng/ml and 36 +/- 14 ng/ml in placebo and methyl-
prednisolone experiments, respectively. As shown
in Fig. 2, exercise was accompanied by significant
changes of EL in both trials. Maximal EL values
reached after 20 min exercise were 102 + 26 and
263 +_ 134 ng/ml in control (p < 0.05) and methyl-
prednisolone (p < 0.02) groups, respectively.
Plasma elastase levels reached at the end of exercise
on methylprednisolone were significantly higher
than after placebo (p <0.05). After 20 min
recovery, plasma elastase levels did not differ
significantly from baseline values just before
exercise. There was a significant relationship
between EL and PMN in methylprednisolone trial
only (r 0.72; p < 0.005).
Resting MPO was unaffected by placebo and
methylprednisolone absorption. The patterns of
MPO changes suring exercise and recovery (Fig.
3) were similar in both experimental conditions.
A significant increase (+110%; p < 0.05) of
mean MPO values was observed after 20 min
exercise. This variable returned to pre-exercise
levels on recovery. All subjects complained of
muscle soreness 48 h after exercise. The rate of
soreness ranged between 3 and 7 in the two trials.
While methylprednisolone had no effect on the
exercise-induced change of MPO, this drug
amplified the exercise-induced increase of EL.
The positive relationship between EL and PMN
suggest that this effect of methylprednisolone
could be explained, at least in part, by the
increase of PMN count.
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FIG. 2. Mean plasma concentration of elastase as a function of time in
the two experimental conditions (see Fig. 1). **Significantly different
from baseline level" p < 0.05 and p < 0.005, respectively.
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FIG. 3. Mean plasma concentration of myeloperoxidase as a function of
time in the two experimental conditions (see Fig. 1). *Significantly
different from baseline level" p < 0.05.
Discussion
The marked neutrophilia observed after methyl-
prednisolone is in agreement with literature dealing
with the effects of corticoids on PMN count,
15 and
clearly demonstrates the efficacy ofdrug absorption.
While the influx of cells from the bone marrow was
probably the principal mechanism underlying the
increase in resting PMN count following methyl-
prednisolone,
15 the early neutrophilia observed
during the running test probably resulted from
PMN demargination under the effects of increased
secretion of catecholamines and hemodynamic
changes associated with exercise.
6
The significant increase of EL and MPO
accompanying exercise is in agreement with the
results of previous studies where strenuous exercise
was found to induce PMN activation.
>5 Although
the mechanisms responsible for this transient
activation of PMNs are not fully understood, there
are, however, several lines of evidence suggesting
that this early PMN response could be a part of an
acute inflammatory response to muscles and/or
connective tissue damage.3’5 Consistent with this
view are the significant relationship between MPO
and the plasma level of the complement split
product C5a as well as the changes of these variables
following a similar time frame during a 20 min
exercise test at 80% /rOgmax.4 The DOMS
symptoms reported in all subjects lend further
support to this assumption. According to Smith,
8
it seems tenable to relate DOMS to an acute
inflammatory reaction where tissue injury could be
the initiating event.
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The recent work by Hasson eta/.,
7 suggested that
products derived from the metabolism of ar-
achidonic acid could be involved in this process.
They showed that an anti-inflammatory drug
inhibiting the enzyme cyclooxygenase (Ibuprofen)
was effective in reducing DOMS and improving
performance recovery when given before strenuous
eccentric exercise. These findings prompted us to
verify whether a steroidal anti-inflammatory agent
inhibiting the metabolism of arachidonic acid could
reduce DOMS and decrease the exercise-induced
release of elastase and myeloperoxidase. Surpris-
ingly, we found that the increase in plasma elastase
level accompanying exercise was markedly am-
plified by methylprednisolone. The precise mechan-
isms by which methylprednisolone amplified the
exercise-induced elastase release and the possible
consequences of this phenomenon obviously need
further studies. Nevertheless, the significant re-
lationship between PMN and EL, suggest that this
effect could be related to an influx of cells from the
bone marrow. It should be kept in mind, however,
that other mechanisms could also be involved, such
as an alteration of the removal rate of elastase from
the blood.
On the contrary, there were no effects of
methylprednisolone on the exercise-induced
changes of MPO. As myeloperoxidase and
elastase are contained within the same granules of
PMN, this lack of effect of methylprednisolone on
MPO is an unexpected finding that we are unable
to explain. Relevant experiments in this field
would verify whether methylprednisolone could
alter the metabolism of elastase and myeloperox-
idase.
The subjective DOMS symptoms did not seem
to be altered by the drug. It should be kept in
mind, however, that only four subjects participated
in this study. Furthermore, the method we used to
evaluate muscle soreness was purely empirical. As
a consequence, these results are at best suggestive.
Further experiments with more appropriate
methods of DOMS scoring may prove helpful in
studying the effects of anti-inflammatory drugs on
muscle soreness.
Despite the low number of subjects who took
part in this study, these preliminary results
showed that a single oral dose of methylpredniso-
lone did not decrease the exercise-induced release
of two specific markers of PMN activation. In
comparison with placebo, methylprednisolone
seemed to amplify the exercise-induced increase of
EL.
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